| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
acyl-CoA thioesterase 1 | 0.780 | 0.192 | 6.4E-05 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 17 | 0.678 | 0.385 | 2.8E-15 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
amyloid P component, serum | 0.531 | 0.808 | 3.2E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
annexin A2 | 0.453 | 0.808 | 9.8E-05 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2015 | ||||||||
|
annexin A4 | 0.599 | 0.692 | 1.2E-08 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
annexin A7 | 0.631 | 0.615 | 8.6E-10 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.540 | None | 1.000 | 1 | 0 | 1997 | 2016 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1994 | 2019 | ||||||||
|
ASH1 like histone lysine methyltransferase | 0.623 | 0.577 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
asparagine synthetase (glutamine-hydrolyzing) | 0.595 | 0.692 | 9.4E-06 |
|
group | 0.500 | None | 1.000 | 1 | 0 | 1976 | 2017 | ||||||||
|
ATPase copper transporting beta | 0.529 | 0.654 | 4.8E-30 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2001 | 2017 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
BTB domain containing 11 | 0.839 | 0.192 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
C-C motif chemokine receptor 4 | 0.510 | 0.731 | 6.9E-02 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
calsyntenin 2 | 0.716 | 0.423 | 3.5E-06 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
carnitine palmitoyltransferase 1B | 0.653 | 0.538 | 1.5E-11 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1998 | 2020 | ||||||||
|
cell death inducing DFFA like effector a | 0.751 | 0.269 | 5.6E-06 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2014 | 2017 | ||||||||
|
cell growth regulator with EF-hand domain 1 | 1.000 | 0.077 | 4.7E-08 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cellular retinoic acid binding protein 1 | 0.631 | 0.615 | 5.9E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
chimerin 2 | 0.711 | 0.615 | 2.3E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
coiled-coil domain containing 134 | 0.769 | 0.308 | 6.0E-07 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 |